Urakawa, Hiroshi <br/><br/>
Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.  [electronic resource] 

 -  Clinical orthopaedics and related research  Nov 2009 
 - 2932-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-1132 
<br/><br/><label>Standard No.: </label>10.1007/s11999-009-0814-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Biomarkers, Tumor--blood<br/>Bone Neoplasms--mortality<br/>Chemotherapy, Adjuvant<br/>Chi-Square Distribution<br/>Child<br/>Child, Preschool<br/>Cohort Studies<br/>Combined Modality Therapy<br/>Confidence Intervals<br/>Cyclooxygenase 2--blood<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoplasm Invasiveness--pathology<br/>Neoplasm Staging<br/>Osteosarcoma--mortality<br/>Pilot Projects<br/>Predictive Value of Tests<br/>Probability<br/>Prognosis<br/>Proportional Hazards Models<br/>Risk Assessment<br/>Survival Analysis<br/>Treatment Outcome<br/>Upper Extremity<br/>Young Adult